CYB003: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 2 1 Phase 3 1

Condition	Trials
Depression	2
Anxiety	1
Depression - Major Depressive Disorder	1
Depression Disorder	1
Depression Disorders	1
Depression in Adults	1
Major Depressive Disorder	1
Major Depressive Disorder (MDD)	1

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
NCT06820723 · Phase: Phase 2 · Ages: 21 Years to 65 Years · Sex: All (male and female) · 1 location
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 69 locations

2 recruiting trials across 8 conditions.

No. For the full record, search ClinicalTrials.gov.